VRAC and Rho in pulmonary EC proliferation

VRAC 和 Rho 在肺 EC 增殖中的作用

• 批准号: 6728397
• 负责人: David M RODMAN
• 金额: $ 22.48万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6728397
• 关键词: angiogenesis; cell morphology; cell proliferation; guanine nucleotide binding protein; human tissue; hypoxia; membrane channels; mitogens; physiologic stressor; potassium channel; pulmonary artery; pulmonary hypertension; respiratory hypoxia; tissue /cell culture; vascular endothelial growth factors; vascular endothelium; vascular endothelium permeability; voltage gated channel

DESCRIPTION (provided by applicant): Proliferation of pulmonary endothelial cells (EC) is required for normal lung development and is involved in the pathogenesis of the vaso-occlusive plexiform lesions that complicate advanced pulmonary hypertension. The role of ion channels in regulating pulmonary EC cell cycle has not been fully elucidated. Recently, volume-regulated anion channels (VRAC) have been implicated in modulating angiogenesis. These channels are classically associated with the current activated by cell swelling (Icswell). We provide evidence that the EC mitogen VEGF activates VRAC, swelling and VEGF activate distinct signaling pathways, and blockade of VRAC completely inhibits proliferation of human pulmonary microvascular EC (HPMVEC). Based on this information we hypothesize: Activation of VRAC is a critical step in mitogenic stimulation of pulmonary endothelial cells, Divergent signaling pathways activated by endothelial cell swelling or mitogens result in tmique patterns of gene activation and Acute and chronic hypoxia activate VRAC and gene expression utilizing similar signaling pathways to cell swelling and mitogens, respectively. We propose three specific aims: 1) Test the hypothesis in human PMVEC that while mitogens and cell swelling both activate VRAC, distinct upstream signaling pathways link the stimuli to channel activation. 2) Test the hypothesis that mitogens and cell swelling activate unique patterns of gene expression dependent both on activation of VRAC and the distinct signaling pathways associated with VRAC activation. 3) Test the hypothesis that acute and chronic hypoxia act via mechanisms similar to cell swelling and mitogens, respectively. Upon completion of our studies we anticipate having more fully defined the role of VRAC and associated signaling pathways in regulation of pulmonary endothelial cell proliferation; work we anticipate will provide important clues to the pathogenesis of pulmonary vascular disease.

描述(由申请人提供)： 肺内皮细胞(EC)的增殖是正常肺发育所必需的，参与了血管闭塞性丛状病变并发进展性肺动脉高压的发病机制。离子通道在调节肺内皮细胞周期中的作用尚未完全阐明。最近，容量调节阴离子通道(Vrac)被认为参与了血管生成的调节。这些通道通常与细胞肿胀(Icswell)激活的电流有关。我们提供的证据表明，内皮细胞有丝分裂原VEGF激活vrac，肿胀和VEGF激活不同的信号通路，阻断vrac可完全抑制人肺微血管内皮细胞(HPMVEC)的增殖。根据这一信息，我们假设：vrac的激活是肺内皮细胞有丝分裂刺激的关键步骤，内皮细胞肿胀或有丝分裂原激活的不同信号通路导致基因激活的不同模式，而急性和慢性缺氧分别利用与细胞肿胀和有丝分裂原相似的信号途径激活vrac和基因表达。 我们提出了三个具体的目标：1)在人PMVEC中测试这一假设，即当有丝分裂原和细胞肿胀都激活vrac时，不同的上游信号通路将刺激与通道激活联系起来。2)验证有丝分裂原和细胞肿胀激活依赖于vrac激活和与vrac激活相关的不同信号通路的独特基因表达模式的假设。3)检验急性和慢性缺氧分别通过类似于细胞肿胀和有丝分裂原的机制起作用的假设。在我们的研究完成后，我们预计将更充分地确定vrac及其相关信号通路在调节肺内皮细胞增殖中的作用；我们预计这项工作将为肺血管疾病的发病机制提供重要线索。